Erratum to: Treatment with mefolinate (5-methyltetrahydrofolate), but not folic acid or folinic acid, leads to measurable 5-methyltetrahydrofolate in cerebrospinal fluid in methylenetetrahydrofolate reductase deficiency (JIMD Reports, (2016) 29, (103-107), 10.1007/8904_2016_529)

L. Knowles; A. A.M. Morris; J. H. Walter

ArticleOPEN ACCESS

Erratum to: Treatment with mefolinate (5-methyltetrahydrofolate), but not folic acid or folinic acid, leads to measurable 5-methyltetrahydrofolate in cerebrospinal fluid in methylenetetrahydrofolate reductase deficiency (JIMD Reports, (2016) 29, (103-107), 10.1007/8904_2016_529)

Knowles L
Morris A
Walter J

JIMD Reports

DOI: 10.1007/8904_2016_574

8Citations

1Readers

Abstract

The final sentence of the abstract should read ‘Only treatment with oral 5-MTHF given as calcium mefolinate at doses of 15–60 mg/day resulted in an increase in CSF 5-MTHF’.

Cite

CITATION STYLE

APA

Knowles, L., Morris, A. A. M., & Walter, J. H. (2016). Erratum to: Treatment with mefolinate (5-methyltetrahydrofolate), but not folic acid or folinic acid, leads to measurable 5-methyltetrahydrofolate in cerebrospinal fluid in methylenetetrahydrofolate reductase deficiency (JIMD Reports, (2016) 29, (103-107), 10.1007/8904_2016_529). JIMD Reports. Springer. https://doi.org/10.1007/8904_2016_574

Erratum to: Treatment with mefolinate (5-methyltetrahydrofolate), but not folic acid or folinic acid, leads to measurable 5-methyltetrahydrofolate in cerebrospinal fluid in methylenetetrahydrofolate reductase deficiency (JIMD Reports, (2016) 29, (103-107), 10.1007/8904_2016_529)

Abstract

Cite

Register to see more suggestions